CoChat

LOST to follow-up Information in Trials (LOST-IT): a protocol on the potential impact

Open access
Akl, Elie A, Briel, Matthias, You, John J, Lamontagne, Francois, Gangji, Azim, Cukierman-Yaffe, Tali, Alshurafa, Mohamad, Sun, Xin, Nerenberg, Kara A, Johnston, Bradley C, Vera, Claudio, Mills, Edward J, Bassler, Dirk, Salazar, Arturo, Bhatnagar, Neera, Busse, Jason W, Khalid, Zara, Walter, SD, Cook, Deborah J, Schünemann, Holger J, Altman, Douglas G, Guyatt, Gordon H · 2009 · Trials
Cited by 90

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Background: Incomplete ascertainment of outcomes in randomized controlled trials (RCTs) is likely to bias final study results if reasons for unavailability of patient data are associated with the outcome of interest. The primary objective of this study is to assess the potential impact of loss to follow-up on the estimates of treatment effect. The secondary objectives are to describe, for published RCTs, (1) the reporting of loss to follow-up information, (2) the analytic methods used for handling loss to follow-up information, and (3) the extent of reported loss to follow-up. Methods: We will conduct a systematic review of reports of RCTs recently published in five top general medical journals. Eligible RCTs will demonstrate statistically significant effect estimates with respect to primary outcomes that are patient-important and expressed as binary data. Teams of 2 reviewers will independently determine eligibility and extract relevant information from each eligible trial using standardized, pre-piloted forms. To assess the potential impact of loss to follow-up on the estimates of treatment effect we will, for varying assumptions about the outcomes of participants lost to follow-up (LTFU), calculate (1) the percentage of RCTs that lose statistical significance and (2) the mean change in effect estimate across RCTs. The different assumptions we will test are the following: (1) none of the LTFU participants had the event; (2) all LTFU participants had the event; (3) all LTFU participants in the treatment group had the event; none of those in the control group had it (worst case scenario); (4) the event incidence among LTFU participants (relative to observed participants) increased, with a higher relative increase in the intervention group; and (5) the event incidence among LTFU participants (relative to observed participants) increased in the intervention group and decreased in the control group. Discussion: We aim to make our objectives and methods transparent. The results of this study may have important implications for both clinical trialists and users of the medical literature.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1745-6215-10-40

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 90

Metadata

Authors
Akl, E. A., Briel, M., You, J. J., Lamontagne, F., Gangji, A., Cukierman-Yaffe, T., Alshurafa, M., Sun, X., Nerenberg, K. A., Johnston, B. C., Vera, C., Mills, E. J., Bassler, D., Salazar, A., Bhatnagar, N., Busse, J. W., Khalid, Z., Walter, S., Cook, D. J., Schünemann, H. J., Altman, D. G., & Guyatt, G. H.
Venue
Trials
Published
2009-06-11
Volume
10
Issue
1
Pages
40-40
ISSN
1745-6215 (ISSN-L)
OpenAlex
W2126650051
Cited by
90
References
7
FWCI
7.56
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: LOST to follow-up Information in Trials (LOST-IT): a protocol on the potential impact. https://app.cochat.ai/papers/10.1186/1745-6215-10-40
The paper
Akl, E. A., Briel, M., You, J. J., Lamontagne, F., Gangji, A., Cukierman-Yaffe, T., Alshurafa, M., Sun, X., Nerenberg, K. A., Johnston, B. C., Vera, C., Mills, E. J., Bassler, D., Salazar, A., Bhatnagar, N., Busse, J. W., Khalid, Z., Walter, S., Cook, D. J., . . . Guyatt, G. H. (2009). LOST to follow-up Information in Trials (LOST-IT): a protocol on the potential impact. Trials. https://doi.org/10.1186/1745-6215-10-40

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.